Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Intraarticular Application of Opioids versus Glucocorticoids versus Placebo in Gonarthritis
ISRCTN ISRCTN72633488
ClinicalTrials.gov identifier
Public title Intraarticular Application of Opioids versus Glucocorticoids versus Placebo in Gonarthritis
Scientific title
Acronym N/A
Serial number at source N/A
Study hypothesis Assessment of efficacy and safety of intraarticular applicated Morphine versus Dexamethasone versus Placebo in gonarthritis in inflammatory rheumatic disease
Lay summary
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment Germany
Disease/condition/study domain Gonarthritis in inflammatory rheumatic disease
Participants - inclusion criteria 1. Age 19-70
2. Gonarthritis with sonographically evident effusion in inflammatory rheumatic disease
3. Visual analogue score (VAS) pain >30 mm
4. Body weight 50-90 kg
5. Written informed consent
Participants - exclusion criteria 1. Pregnancy, lactation
2. Severe or opportunistic infection, infection of the knee
3. Malignant diseases
4. Any other severe diseases
5. Platelets <100/nl, Quick <50
6. Significant findings during clinical examination
7. Participation in a clinical trial within 30 days before inclusion
8. Abuse of hard drugs, benzodiacepines, analgesics, alcohol
9. Therapy with anticoagulants
Anticipated start date 01/01/2004
Anticipated end date 01/01/2006
Status of trial Completed
Patient information material
Target number of participants 60
Interventions Single injection of Morphine 3 mg or Dexamethasone 4 mg or Placebo during needle arthroscopy. Rearthroscopy after 7 days.
Primary outcome measure(s) Improvement of VAS pain of at least 20 mm on a 0-100 scale.
Secondary outcome measure(s) Impovement of a numeric pain scale, sleep quality, global daily activity, knee mobility with Lysholm and Gilquist Score, Western Ontario McMaster Universities Osteoarthritis (WOMAC) index, relief of pain on a numeric scale from 0-3.
Sources of funding German Research Foundation (Deutsche Forschungsgemeinschaft) KFO 100
Trial website
Publications
Contact name Prof  Joachim  Sieper
  Address Charité Campus Benjamin Franklin
Dept of Rheumatology
Hindenburgdamm 30
  City/town Berlin
  Zip/Postcode 12200
  Country Germany
  Tel +49 (0)3084454414
  Fax +49 (0)3084454149
  Email joachim.sieper@charite.de
Sponsor Charité - University Medicine Berlin (Charité - Universitätsmedizin Berlin) (Germany)
  Address Benjamin Franklin Campus
Department of Rheumatology
Hindenburgdamm 30
  City/town Berlin
  Zip/Postcode 12200
  Country Germany
  Tel +49 (0)3084454414
  Fax +49 (0)3084454149
  Email joachim.sieper@charite.de
  Sponsor website: http://www.charite.de
Date applied 24/08/2005
Last edited 06/02/2008
Date ISRCTN assigned 21/10/2005
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central